Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

DOI Web Site Web Site 1 Citations

Journal

  • The Lancet

    The Lancet 387 (10014), 136-145, 2016-01

    Elsevier BV

Citations (1)*help

See more

Keywords

Report a problem

Back to top